Literature DB >> 17220338

Global DNA methylation level in whole blood as a biomarker in head and neck squamous cell carcinoma.

Debra Ting Hsiung1, Carmen J Marsit, E Andres Houseman, Karen Eddy, C Sloane Furniss, Michael D McClean, Karl T Kelsey.   

Abstract

BACKGROUND: Head and neck squamous cell carcinoma (HNSCC) is commonly associated with tobacco and alcohol exposures, although dietary factors, particularly folate, and human papillomavirus, are also risk factors. Epigenetic alterations are increasingly implicated in the initiation and progression of cancer. Genome-wide (global) hypomethylation seems to occur in early neoplasia and is a feature of genomic DNA derived from solid tumor tissues, including HNSCC. This study aimed to determine whether global methylation in DNA derived from whole blood, a proxy tissue, is associated with HNSCC and to assess potential modification of this property by environmental or behavioral risk factors.
METHODS: Global DNA methylation levels were assessed using a modified version of the combined bisulfite restriction analysis of the LRE1 sequence in a population-based case-control study of HNSCC from the Boston area.
RESULTS: Hypomethylation lead to a significant 1.6-fold increased risk for disease (95% confidence interval, 1.1-2.4), in models controlled for other HNSCC risk factors. Smoking showed a significant differential effect (P < 0.03) on blood relative methylation between cases and controls. Furthermore, in cases, variant genotype in the MTHFR gene and low folate intake showed relationships with decreased global methylation, whereas in controls, antibody response to human papillomavirus 16 was associated with an increased global methylation level. DISCUSSION: DNA hypomethylation in nontarget tissue was independently associated with HNSCC and had a complex relationship with the known risk factors associated with the genesis of HNSCC.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17220338     DOI: 10.1158/1055-9965.EPI-06-0636

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  164 in total

1.  Genomic methylation changes over time in peripheral blood mononuclear cell DNA: differences by assay type and baseline values.

Authors:  Hui-Chen Wu; Qiao Wang; Lissette Delgado-Cruzata; Regina M Santella; Mary Beth Terry
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2012-06-04       Impact factor: 4.254

Review 2.  DNA methylation in white blood cells: association with risk factors in epidemiologic studies.

Authors:  Mary Beth Terry; Lissette Delgado-Cruzata; Neomi Vin-Raviv; Hui Chen Wu; Regina M Santella
Journal:  Epigenetics       Date:  2011-07-01       Impact factor: 4.528

3.  Variable DNA methylation is associated with chronic obstructive pulmonary disease and lung function.

Authors:  Weiliang Qiu; Andrea Baccarelli; Vincent J Carey; Nadia Boutaoui; Helene Bacherman; Barbara Klanderman; Stephen Rennard; Alvar Agusti; Wayne Anderson; David A Lomas; Dawn L DeMeo
Journal:  Am J Respir Crit Care Med       Date:  2011-12-08       Impact factor: 21.405

4.  Adult global DNA methylation in relation to pre-natal nutrition.

Authors:  L H Lumey; Mary Beth Terry; Lissette Delgado-Cruzata; Yuyan Liao; Qiao Wang; Ezra Susser; Ian McKeague; Regina M Santella
Journal:  Int J Epidemiol       Date:  2011-09-29       Impact factor: 7.196

5.  Predictors of global methylation levels in blood DNA of healthy subjects: a combined analysis.

Authors:  Zhong-Zheng Zhu; Lifang Hou; Valentina Bollati; Letizia Tarantini; Barbara Marinelli; Laura Cantone; Allen S Yang; Pantel Vokonas; Jolanta Lissowska; Silvia Fustinoni; Angela C Pesatori; Matteo Bonzini; Pietro Apostoli; Giovanni Costa; Pier Alberto Bertazzi; Wong-Ho Chow; Joel Schwartz; Andrea Baccarelli
Journal:  Int J Epidemiol       Date:  2010-09-15       Impact factor: 7.196

6.  Associations of LINE-1 DNA Methylation with Preterm Birth in a Prospective Cohort Study.

Authors:  Heather H Burris; Sheryl L Rifas-Shiman; Andrea Baccarelli; Letizia Tarantini; Caroline E Boeke; Ken Kleinman; Augusto A Litonjua; Janet W Rich-Edwards; Matthew W Gillman
Journal:  J Dev Orig Health Dis       Date:  2012-06       Impact factor: 2.401

7.  Mature microRNA sequence polymorphism in MIR196A2 is associated with risk and prognosis of head and neck cancer.

Authors:  Brock C Christensen; Michele Avissar-Whiting; Lauren G Ouellet; Rondi A Butler; Heather H Nelson; Michael D McClean; Carmen J Marsit; Karl T Kelsey
Journal:  Clin Cancer Res       Date:  2010-05-25       Impact factor: 12.531

Review 8.  Epigenetic research in cancer epidemiology: trends, opportunities, and challenges.

Authors:  Mukesh Verma; Scott Rogers; Rao L Divi; Sheri D Schully; Stefanie Nelson; L Joseph Su; Sharon A Ross; Susan Pilch; Deborah M Winn; Muin J Khoury
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2013-12-10       Impact factor: 4.254

Review 9.  Age-related cataracts: Role of unfolded protein response, Ca2+ mobilization, epigenetic DNA modifications, and loss of Nrf2/Keap1 dependent cytoprotection.

Authors:  Palsamy Periyasamy; Toshimichi Shinohara
Journal:  Prog Retin Eye Res       Date:  2017-08-31       Impact factor: 21.198

10.  LINE-1 methylation in peripheral blood and the risk of melanoma in melanoma-prone families with and without CDKN2A mutations.

Authors:  Paula L Hyland; Laura S Burke; Ruth M Pfeiffer; Lisa Mirabello; Margaret A Tucker; Alisa M Goldstein; Xiaohong R Yang
Journal:  Melanoma Res       Date:  2013-02       Impact factor: 3.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.